prostate cancer Archives - Page 56 of 64 - Sperling Prostate Center

Agreeing on Active Surveillance Terminology

Medical language is filled with technical terms that are virtually incomprehensible for many patients because in many cases they have Latin or Greek roots. Even when doctors are speaking English, however, they aren’t all using the same terms for the same thing. Take, for example, the expression Active Surveillance (AS). AS is often understood by keep reading

Prostate Cancer Drugs Are Linked to Dementia

Men need testosterone, but prostate cancer does not. While there is new evidence that use of testosterone replacement therapy does not lead to prostate cancer, once prostate cancer has occurred, it appears to be fueled by testosterone. This is particularly bad news if prostate cancer has penetrated the edges of the gland capsule and begun keep reading

Why You Should Think Twice Before Having Another Drink

What do you know about the effects of alcohol consumption on your body? Everyone knows that alcohol abuse (heavy drinking) will eventually cause liver damage. But wait, there’s more. Those with a high level of consumption are putting other organs on the line: Brain – alcohol impairs clear thinking and coordination because it muddles the keep reading

How Additional Treatments after Prostatectomy Affect Quality of Life

In the urologic world, there is a longstanding bias that surgical removal of the prostate gland, or radical prostatectomy (RP), is the preferred treatment for prostate cancer (PCa). It is based in the outdated belief that all PCa is a) multifocal, and b) likely to spread beyond the gland if untreated. Thus, it seemed logical keep reading

Multiparametric MRI Before Prostate Biopsy: Dawn of a New Era

“Change is inevitable. Progress is optional.” Tony Robbins In medicine, change sometimes happens with two steps forward but one step back. For example, in the early 20th century, delivering babies in hospitals became more popular than home births in order to have “painless” births with anesthesia. However, for many women the higher complication and infection keep reading

Less Expensive MRI Rules Out Unnecessary Prostate Biopsy

Two problems face men who have a high PSA or abnormal digital rectal exam (DRE). First, they are often referred for a conventional TRUS needle biopsy of the prostate because there is suspicion of prostate cancer (PCa). Second, multiparametric MRI is considered too time-consuming and expensive for routine determination of the need for a biopsy. keep reading

Circadian Rhythm: Heed Your Internal Clock to Prevent Prostate Cancer

The earth completes a full rotation on its axis every 24 hours. For the majority of creatures – including humans – who do not live near either the north or south pole, about half of the time it’s day, and the other half is night. With relatively few fluctuations, this daily division of daylight and keep reading

The Sperling Prostate Center Joins Focal MRgFUS Clinical Trial

The Sperling Prostate Center joins a prestigious group of academic and community medical centers participating in a Phase Three clinical trial of a new prostate cancer focal treatment. Dr. Sperling is the Principal Investigator at our Boca Raton, FL study site. The treatment under investigation is MRI-guided Focused Ultrasound (MRgFUS), a noninvasive technology for the keep reading

Why Choose the Sperling Prostate Center for Active Surveillance?

With Active Surveillance on the rise, one would think that doctors who support AS for their prostate cancer patients have similar commitment and protocols. A new study (Sep. 2016) in the British Journal of Urology International (BJUI) spells out 8 areas of qualitative differences among AS doctors: physician comfort with active surveillance protocol selection beliefs keep reading

British Study Confirms the Role of mpMRI Before Biopsy

Terrific news and a great way to start off 2017! On January 17, the prestigious medical journal The Lancet issued online publication of a British study, “Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study” (Ahmed et al., 2017[i]). This large trial validated the importance of multiparametric keep reading

Tag: prostate cancer